Format

Send to

Choose Destination
JAMA Intern Med. 2017 Aug 1;177(8):1207-1210. doi: 10.1001/jamainternmed.2017.1313.

Publication and Reporting of the Results of Postmarket Studies for Drugs Required by the US Food and Drug Administration, 2009 to 2013.

Author information

1
Office of Public Health Strategy and Analysis, US Food and Drug Administration, Silver Spring, Maryland.
2
Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
PMID:
28505214
PMCID:
PMC5818792
DOI:
10.1001/jamainternmed.2017.1313
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center